Evidence map›Paper›PMID 28446613›Full record

ArticleEMBO reports2017

Structural basis for ligand capture and release by the endocytic receptor ApoER2.

Hidenori Hirai, Norihisa Yasui, Keitaro Yamashita, Sanae Tabata, Masaki Yamamoto, Junichi Takagi, Terukazu Nogi

Open access · bronzeAbstract read
In one paragraph

Article in EMBO reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. The Reelin Receptors Apolipoprotein E receptor 2 (ApoER2) and VLDL Receptor.International journal of molecular sciences · 2018
    Review
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Hidenori HiraiInstitute for Protein Research, Osaka University, Osaka, Japan.
Norihisa YasuiGraduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.
Keitaro YamashitaRIKEN SPring-8 Center, Hyogo, Japan.
Sanae TabataInstitute for Protein Research, Osaka University, Osaka, Japan.
Masaki YamamotoRIKEN SPring-8 Center, Hyogo, Japan.
Junichi TakagiInstitute for Protein Research, Osaka University, Osaka, Japan.
Terukazu NogiGraduate School of Medical Life Science, Yokohama City University, Yokohama, Japan nogi@tsurumi.yokohama-cu.ac.jp.ORCID 0000-0001-8663-3519
Protein Research Foundation · JPSPring-8 · JPOkayama University · JPYokohama City University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Apolipoprotein E receptor 2 (ApoER2) is a close homologue of low-density lipoprotein receptor (LDLR) that mediates the endocytosis of ligands, including LDL particles. LDLR family members have been presumed to explore a large conformational space to capture ligands in the extended conformation at the cell surface. Ligands are subsequently released through a pH-titrated structural transition to a self-docked, contracted-closed conformation. In addition to lipoprotein uptake, ApoER2 is implicated in signal transduction during brain development through capture of the extracellular protein reelin. From crystallographic analysis, we determine that the full-length ApoER2 ectodomain adopts an intermediate contracted-open conformation when complexed with the signaling-competent reelin fragment, and we identify a previously unappreciated auxiliary low-affinity binding interface. Based on mutational analyses, we propose that the pH shift during endocytosis weakens the affinity of the auxiliary interface and destabilizes the ligand-receptor complex. Furthermore, this study elucidates that the contracted-open conformation of ligand-bound ApoER2 at neutral pH resembles the contracted-closed conformation of ligand-unbound LDLR at acidic pH in a manner suggestive of being primed for ligand release even prior to internalization.

Indexed as

AnimalsCell Adhesion Molecules, NeuronalCHO CellsCricetulusCrystallographyEndocytosisEndosomesExtracellular Matrix ProteinsHumansHydrogen-Ion ConcentrationLDL-Receptor Related ProteinsLigandsLipoproteins, LDLNerve Tissue ProteinsNeuronsProtein ConformationCell Adhesion Molecules, NeuronalExtracellular Matrix ProteinsLDL-Receptor Related ProteinsLigandsLipoproteins, LDLlow density lipoprotein receptor-related protein 8Nerve Tissue ProteinsReceptors, LDLReelin ProteinRELN protein, humanSerine EndopeptidasesApoER2endocytic receptorLDLR familyligand uptakereelin

Identifiers

PMID28446613
PMCPMC5452030
OpenAlexW2608286328

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.